Overdose Lifeline has been able to secure additional resources to provide reimbursement for physicians, nurse practitioners and physicians assistants willing to become eligible to prescribe medication assisted treatment (MAT) / medication for opioid use disorder (MOUD).
Tools are now available to provide an evidence-based, medication to treat opioid use disorder.
MAT/MOUD is the use of medications in combination with counseling and behavioral therapies. Research has shown that removing an individual’s drug use through detoxification without the use of medications has a high failure rate of >90% within 3 months. A common misconception associated with MAT/MOUD is that it substitutes one drug for another.
Rather, these medications relieve the withdrawal symptoms and psychological cravings that cause chemical imbalances in the body. MAT/MOUD programs provide a safe and controlled level of medication to overcome the use of an abused opioid. Research has shown that when provided at the proper dose, medications used in MAT/MOUD have no adverse effects on a person’s intelligence, mental capability, physical functioning or employability.
- Take the training and
- See your first patient
Overdose Lifeline, Inc. will help you manage this easy 3-step process.
- Simply visit this website and take the training on the PCSS website: https://pcssnow.org/medication-assisted-treatment/. The Training is Free to You and is 8 hours in length.
- Then visit the ODL Mat Waiver webpage, complete the online form and submit your training verification, first patient served signed letter* and W-9 form. MAT Waiver page: https://www.overdoselifeline.org/matwaiver.html
- Receive the following reimbursement from the pilot program via Overdose Lifeline, Inc:
— $600 for training and an additional $600 for seeing your first patient
— For treating pregnant women: a premium rate of $800 for training and an additional $800 for seeing your first patient
Note: Because this is a pilot program, there is a maximum number of allowed patients, so participation is on a first come, first served basis. All patients will need to be seen on or before April 30, 2020 to qualify for the reimbursement.
*First Patient Served Signed Letter: A patient letter of attestation to include HIPPA protected information regarding who/when and what was prescribed then signed by you.
For questions, please contact Overdose Lifeline, Inc.: email@example.com or call 844-554-3354